Jet fuel company’s leader calls South Dakota ‘a difficult place to do business’

The leader of the company that abandoned its immediate plans to build a $2.6 billion ethanol-based jet fuel plant in Lake ...

Boehringer’s zongertinib demonstrated a 77% objective response rate in treatment-naïve ...

Ingelheim, Germany / Ridgefield, Connecticut, U.S. Data from the Phase Ib Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC were presented ...